← Eichor
Study identifier: NCT05399537 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Condition: Regional Citrate Anticoagulation (RCA) · Continuous Renal Replacement Therapy (CRRT) · Acute Kidney Injury (AKI)  ·  Sponsor: Vantive Health LLC

PhasePhase 3
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prismocitrate 18 is a continuous renal replacement therapy (CRRT) solution to be used as a renal replacement solution and as an anticoagulant to prevent blood clotting in the extracorporeal circuit. The delivery of CRRT therapy is provided by the PrisMax System which includes regional citrate anticoagulation (RCA) software to facilitate citrate and calcium compensation prescription. The objectives of this study are: 1) to confirm the safety of Prismocitrate 18 in patients receiving CRRT using continuous venovenous hemodiafiltration (CVVHDF) or continuous venovenous hemofiltration (CVVH) and 2) to observe that the software and interface for the PrisMax System Version 3.x with calcium line accessory allows for implementation of regional citrate anticoagulation (RCA) (citrate and calcium dosing) during CRRT with Prismocitrate 18 and intended prescription. The study period of the patient's CRRT will be up to 10 days.

This description comes directly from the study's public registry record.

Talk to the study team

Global CORP Clinical Trials Disclosure  ·  +1 2249484283  ·  Global.CORP.ClinicalTrialsDisclosure@vantive.com

Always discuss trial participation with your own doctor first.

Locations (14)

University of Alabama at Birmingham/UABBirmingham, Alabama, United StatesRecruiting
University of Southern California (USC) / Keck HospitalLos Angeles, California, United StatesRecruiting
University of California Los AngelesLos Angeles, California, United StatesWithdrawn
University of MiamiMiami, Florida, United StatesNot Yet Recruiting
Emory UniversityAtlanta, Georgia, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesNot Yet Recruiting
Bon Secours Mercy Health-Springfield Regional Medical CenterSpringfield, Ohio, United StatesActive Not Recruiting
Geisinger Medical CenterDanville, Pennsylvania, United StatesWithdrawn
Penn State Hershey Medical CenterHershey, Pennsylvania, United StatesWithdrawn
VA Pittsburgh Healthcare SystemPittsburgh, Pennsylvania, United StatesActive Not Recruiting
Medical University of South Carolina (MUSC)Charleston, South Carolina, United StatesRecruiting
Lt. Col. Luke Weathers, Jr. VA Medical CenterMemphis, Tennessee, United StatesRecruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05399537